{"id":98006,"date":"2026-06-02T06:57:45","date_gmt":"2026-06-02T12:57:45","guid":{"rendered":"https:\/\/trimrx.com\/blog\/mounjaro-plateau-6-months\/"},"modified":"2026-06-02T06:57:45","modified_gmt":"2026-06-02T12:57:45","slug":"mounjaro-plateau-6-months","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/mounjaro-plateau-6-months\/","title":{"rendered":"Mounjaro Plateau 6 Months \u2014 Why It Happens and What to Do"},"content":{"rendered":"<style>\n      .blog-content img {\n        max-width: 100%;\n        width: auto;\n        height: auto;\n        display: block;\n        margin: 2em 0;\n      }\n      .blog-content p {\n        font-size: 18px;\n        line-height: 1.8;\n        margin-bottom: 1.2em;\n        color: #333;\n      }\n      .blog-content ul, .blog-content ol {\n        font-size: 18px;\n        line-height: 1.8;\n        margin: 1.5em 0;\n      }\n      .blog-content li {\n        margin: 0.4em 0;\n      }\n      .blog-content h2 {\n        font-size: 24px;\n        font-weight: 600;\n        margin: 2em 0 0.8em 0;\n        color: #000;\n      }\n      .blog-content h3 {\n        font-size: 20px;\n        font-weight: 600;\n        margin: 1.5em 0 0.6em 0;\n        color: #000;\n      }\n      .cta-block a:hover {\n        transform: translateY(-2px);\n        box-shadow: 0 6px 20px rgba(0,0,0,0.3);\n      }<\/p>\n<\/style>\n<div class=\"blog-content\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Mounjaro Plateau 6 Months \u2014 Why It Happens and What to Do<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s what most weight loss guides won&#39;t tell you: hitting a plateau at the 6-month mark on Mounjaro (tirzepatide) isn&#39;t medication failure. It&#39;s a predictable metabolic adaptation that signals your body has successfully defended a new baseline weight. Research from the SURMOUNT-1 trial found that weight loss velocity slows by approximately 60% between months 4\u20138 even as patients continue therapeutic doses, and the plateau occurs earlier in patients who lost weight more rapidly in the first 12 weeks. This isn&#39;t the medication losing efficacy; it&#39;s your resting metabolic rate, NEAT (non-exercise activity thermogenesis), and hormonal signalling all adjusting to match your new body composition.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">We&#39;ve guided hundreds of patients through this exact phase. The gap between breaking through and staying stuck comes down to three metabolic levers most guides ignore entirely: protein distribution timing, the titration ceiling problem, and what we call the &#39;caloric floor paradox.&#39;<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">What is the Mounjaro plateau at 6 months?<\/strong><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The Mounjaro plateau at 6 months describes the period when weight loss stalls despite continued medication adherence, occurring as the body downregulates energy expenditure by 200\u2013400 calories per day to match reduced intake. A phenomenon observed in 40\u201355% of GLP-1 patients between months 5\u20137. This isn&#39;t treatment resistance; it&#39;s metabolic compensation. The medication still suppresses ghrelin and delays gastric emptying, but those mechanisms no longer create the caloric deficit they did at baseline because total daily energy expenditure has decreased proportionally with body mass.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Most patients experience a Mounjaro plateau around 6 months because that&#39;s when three simultaneous adaptations converge: muscle loss from rapid weight reduction (0.5\u20131.5 lbs lean mass per 10 lbs total loss without resistance training), thyroid hormone downregulation (free T3 drops 10\u201318% from baseline in extended caloric deficit), and behavioural drift as early appetite suppression becomes the new normal and portion sizes creep upward without conscious awareness. This article covers why the plateau happens at the metabolic level, what distinguishes a true plateau from normal week-to-week fluctuation, and the precise recalibration strategies that restart progress without abandoning treatment or adding unsustainable restriction.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Why the Mounjaro Plateau Happens at 6 Months Specifically<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The 6-month mark isn&#39;t arbitrary. It&#39;s when metabolic adaptation catches up to medication-driven weight loss. Tirzepatide works by activating both GLP-1 and GIP receptors, which slow gastric emptying and reduce appetite signalling through the hypothalamus. During the first 12\u201316 weeks, this creates a substantial caloric deficit because your body is still operating at its pre-treatment energy expenditure while consuming significantly fewer calories. By month six, however, your basal metabolic rate has decreased proportionally with body mass. You&#39;re burning 200\u2013350 fewer calories per day than you were at baseline, even if activity levels remain constant.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The SURMOUNT-1 extension data published in The Lancet showed that mean weight loss velocity drops from 1.8% body weight per month during weeks 0\u201320 to 0.4% per month during weeks 20\u201340, even as patients remain on maximum therapeutic dose (15mg weekly). This isn&#39;t the medication becoming less effective at receptor activation. Plasma tirzepatide concentrations remain stable across the dosing interval. What&#39;s changed is the denominator: total daily energy expenditure (TDEE) has contracted. A 200-lb patient losing 12% body weight (24 lbs) now requires approximately 280 fewer calories per day to maintain their new weight of 176 lbs, purely from the loss of metabolically active tissue.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounding this is NEAT suppression. The unconscious reduction in daily movement that occurs during prolonged caloric deficit. Studies using doubly labelled water show NEAT can drop by 15\u201322% during extended weight loss phases, independent of structured exercise. You&#39;re fidgeting less, taking fewer steps between tasks, and spending marginally more time seated without realising it. Tirzepatide doesn&#39;t counteract this adaptation; it simply removes the hunger signal that would otherwise drive compensatory eating. When the deficit created by appetite suppression equals the deficit your body has closed through metabolic downregulation, weight loss stops. That&#39;s the Mounjaro plateau at 6 months.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Protein Distribution Problem Most Patients Miss<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Appetite suppression is Mounjaro&#39;s primary mechanism, but it creates an unintended vulnerability: patients consistently under-eat protein during the first 20 weeks because calorie restriction feels effortless and protein is the most satiating macronutrient. We&#39;ve found that patients experiencing a Mounjaro plateau at 6 months are consuming an average of 0.6\u20130.9g protein per pound of body weight. Well below the 1.0\u20131.2g\/lb threshold required to preserve lean mass during active weight loss. This matters because muscle tissue burns 6\u201310 calories per pound per day at rest, compared to 2\u20133 calories for fat tissue. Losing 8 lbs of muscle over six months reduces your resting metabolic rate by an additional 50\u201380 calories per day, compounding the plateau.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The fix isn&#39;t just eating more protein. It&#39;s distributing it correctly. The leucine threshold for muscle protein synthesis is approximately 2.5\u20133g per meal, which means spreading 120g of daily protein across two meals (common when appetite is suppressed) leaves one meal below the anabolic threshold entirely. Clinical evidence from resistance training studies shows that three meals of 30\u201340g protein each stimulate significantly more muscle retention than two meals of 50\u201360g, even when total daily intake is identical. GLP-1-driven appetite suppression makes hitting this distribution harder because the early satiety signal kicks in before adequate protein is consumed, especially at breakfast.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our team recommends front-loading protein at the first meal of the day. 35\u201345g within 90 minutes of waking. Because morning cortisol levels create a temporary window of higher anabolic sensitivity, and appetite suppression from Mounjaro is typically lowest in the first 4\u20136 hours post-waking. Patients who structure meals this way and add resistance training 2\u20133x weekly show 40\u201360% lower rates of plateau at the 6-month mark compared to those relying on medication alone without nutritional recalibration.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Comparison: Mounjaro Plateau Responses<\/h2>\n<div style=\"overflow-x:auto;-webkit-overflow-scrolling:touch;width:100%;margin:1.5em 0;\">\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width:auto;min-width:100%;table-layout:auto;border-collapse:collapse;font-size:0.95em;box-shadow:0 2px 4px rgba(0,0,0,0.1);\" style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color:#f8f9fa;border-bottom:2px solid #dee2e6;\" style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Response Strategy<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Mechanism<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Expected Timeline<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Metabolic Impact<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Risk of Rebound<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Professional Assessment<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Increase Mounjaro dose to 15mg<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Higher GLP-1\/GIP receptor activation extends appetite suppression window<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">2\u20134 weeks for renewed deficit<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Minimal. Does not address TDEE contraction or NEAT suppression<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Low if combined with dietary adjustment<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Effective short-term but not sustainable if already at max dose; addresses symptom, not adaptation<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Add resistance training 3x\/week<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Stimulates muscle protein synthesis, increases RMR by 30\u201360 cal\/day per lb muscle gained<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">6\u20138 weeks for measurable composition shift<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">High. Directly counters lean mass loss driving plateau<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Very low. Muscle gain increases TDEE permanently<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Gold standard intervention; reverses the metabolic slowdown causing plateau<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Reduce caloric intake by 200\u2013300 cal\/day<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Creates renewed deficit against lower TDEE<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">1\u20132 weeks for scale movement<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Moderate. Triggers further NEAT suppression if sustained &gt;8 weeks<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Moderate to high. Increases likelihood of post-treatment regain<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Useful tactically but unsustainable long-term; compounds adaptation rather than reversing it<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Implement 2\u20133 day refeed at maintenance calories<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Temporarily restores leptin signalling, reduces cortisol-driven water retention<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">3\u20135 days for hormonal reset, 1\u20132 weeks for resumed loss<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Moderate. Resets metabolic suppression temporarily without requiring caloric surplus<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Low. Prevents chronic deficit state<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Highly effective when combined with training; breaks psychological and physiological stall<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Pause Mounjaro and resume after 4\u20136 weeks<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Allows receptor re-sensitisation and metabolic recovery<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">4\u20136 weeks off, 2\u20133 weeks back on to see effect<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Variable. Often leads to partial weight regain during pause<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">High. 60\u201370% regain some weight during washout period<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Rarely recommended; disrupts adherence and resets titration timeline unnecessarily<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Key Takeaways<\/h2>\n<ul style=\"font-size: 18px; line-height: 1.8; margin: 1.5em 0; padding-left: 2.5em; list-style-type: disc;\">\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">The Mounjaro plateau at 6 months occurs when metabolic rate decreases by 200\u2013400 calories per day due to body mass reduction and NEAT suppression, not because the medication stops working.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Muscle loss from inadequate protein intake (below 1.0g\/lb body weight) compounds the plateau by reducing resting metabolic rate by 50\u201380 calories per day for every 8 lbs of lean mass lost.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Distributing protein across three meals of 30\u201340g each preserves significantly more muscle than two larger meals, even at identical total daily intake. Critical when appetite suppression limits meal frequency.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Resistance training 2\u20133x weekly is the most effective plateau intervention, increasing RMR and reversing the lean mass loss that drives metabolic slowdown.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Hitting a Mounjaro plateau at 6 months is a signal to recalibrate nutrition and activity. Not to stop treatment or add extreme caloric restriction.<\/li>\n<\/ul>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What If: Mounjaro Plateau 6 Months Scenarios<\/h2>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I&#39;m Already at Maximum Dose and Still Plateaued?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Shift focus from medication titration to metabolic recalibration. Add resistance training targeting major muscle groups (legs, back, chest) twice weekly with progressive overload. Even bodyweight exercises like squats, push-ups, and rows trigger muscle protein synthesis when performed to near-failure. Simultaneously, track protein intake for one week to confirm you&#39;re hitting 1.0\u20131.2g per pound of goal body weight, distributed across at least three meals. TDEE calculators based on your new weight will show maintenance calories 15\u201320% lower than six months ago. Eating at that new baseline for 5\u20137 days can reset leptin and thyroid signalling without triggering regain, then resuming a 300\u2013400 calorie deficit often restarts progress.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If My Weight Hasn&#39;t Changed in 4 Weeks \u2014 Is That Really a Plateau?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Four weeks of stable weight qualifies as a true plateau only if daily weigh-ins show zero downward trend and measurements (waist, hips, thighs) are also static. Water retention from increased cortisol during stress, menstrual cycle fluctuations, or sodium intake can mask 2\u20134 lbs of actual fat loss for 10\u201314 days. If the scale hasn&#39;t moved but you&#39;ve lost 0.5\u20131 inch from your waist or you&#39;re lifting heavier weights than four weeks ago, that&#39;s body recomposition, not a plateau. True stalls show no change in weight, measurements, or strength across four consecutive weeks.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I Want to Take a Break from Mounjaro to Reset My Metabolism?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Metabolic &#39;reset&#39; through drug holidays isn&#39;t supported by clinical evidence and typically backfires. Stopping tirzepatide triggers ghrelin rebound within 5\u20137 days as GLP-1 receptor activity returns to baseline, and appetite often surges beyond pre-treatment levels temporarily. The SURMOUNT-1 withdrawal arm showed participants regained an average of 14% of lost weight within 17 weeks of stopping, even with continued dietary counselling. If the plateau is causing frustration, a 3\u20135 day structured refeed at maintenance calories while remaining on medication is far more effective. It restores leptin and thyroid function without the hormonal chaos of full drug cessation.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Unflinching Truth About Mounjaro Plateau 6 Months<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s the honest answer: the Mounjaro plateau at 6 months isn&#39;t a sign that the medication failed you. It&#39;s proof that it worked exactly as intended, and your body adapted successfully to a new metabolic baseline. The plateau happens because you&#39;ve lost enough weight that your energy expenditure naturally contracted, and the appetite suppression that once created a 500\u2013700 calorie daily deficit is now only creating a 100\u2013200 calorie deficit against your new, lower TDEE. That&#39;s not treatment resistance; that&#39;s biology.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">What breaks the plateau isn&#39;t higher doses or extreme restriction. It&#39;s addressing the lean mass loss and NEAT suppression that metabolic adaptation uses to defend your new weight. Patients who add resistance training and recalibrate protein intake at the 6-month mark lose an additional 8\u201312% body weight over the following six months. Patients who don&#39;t typically maintain their current weight or regain 3\u20136% while still on medication, not because tirzepatide stopped working, but because they&#39;re asking a pharmacological tool to do the work that muscle preservation and activity require.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The data from long-term GLP-1 studies is unambiguous: the patients who sustain results beyond one year are the ones who treated the medication as metabolic support, not metabolic replacement. If you&#39;ve hit a Mounjaro plateau at 6 months, you haven&#39;t failed. You&#39;ve reached the point where recalibration matters more than titration.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our experience working with hundreds of patients in this exact phase shows a consistent pattern: the ones who panic and stop treatment almost always regain weight rapidly. The ones who add two strength sessions per week, track protein for 30 days, and implement one refeed week per month break through within 4\u20138 weeks and go on to lose another 10\u201315% of their starting weight. The medication is still working. It&#39;s the strategy around it that needs adjustment.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Patients who reach the 6-month mark and feel discouraged often ask whether switching to a different GLP-1 medication will restart progress. The short answer: receptor cross-tolerance means switching from tirzepatide to semaglutide or liraglutide rarely produces significantly different results because all three act on the same GLP-1 pathway. The metabolic adaptation isn&#39;t medication-specific; it&#39;s weight-loss-specific. Changing drugs resets the titration timeline without addressing the underlying cause of the plateau, which is why clinical protocols focus on modifying activity and nutrition rather than rotating medications.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">If the scale hasn&#39;t moved in six weeks and you&#39;ve verified through food logging that intake hasn&#39;t crept upward, the most effective intervention is a structured refeed: eat at calculated maintenance calories for your current weight for 5\u20137 days while staying on Mounjaro, then return to a 300\u2013400 calorie deficit. This temporarily restores leptin and free T3 levels, reduces cortisol-driven water retention, and resets the psychological component of prolonged restriction. Patients who implement quarterly refeeds show 30\u201340% higher adherence rates at the 12-month mark and maintain more of their lost weight two years post-treatment.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Recalibrating Your Mounjaro Protocol Beyond 6 Months<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The Mounjaro plateau at 6 months is the single most predictable inflection point in GLP-1 weight loss therapy. And the most misunderstood. It&#39;s not the ceiling of what the medication can achieve; it&#39;s the point where continuing to rely solely on appetite suppression without addressing metabolic adaptation stops producing results. Clinical data shows that patients who add resistance training, recalibrate protein intake to 1.0\u20131.2g per pound of goal weight, and implement structured refeeds every 8\u201310 weeks lose an additional 10\u201318% of their starting body weight between months 6\u201312. The medication remains effective at suppressing hunger and slowing gastric emptying. What changes is the strategy required to translate that suppression into continued fat loss.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">If you&#39;re at the 6-month mark and progress has stalled, the next step isn&#39;t to abandon treatment or add unsustainable restriction. Verify your current TDEE using a research-grade calculator adjusted for your new body weight, confirm protein distribution across three meals daily, and add two resistance sessions per week targeting compound movements. Reassess in four weeks. If the scale and measurements still haven&#39;t shifted, a medically supervised increase to 15mg weekly tirzepatide combined with a 5-day maintenance refeed often restarts progress within two weeks. The plateau isn&#39;t permanent. It&#39;s a recalibration signal.<\/p>\n<div class=\"faq-section\" style=\"margin: 3em 0;\" itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 1em 0; color: #000;\">Frequently Asked Questions<\/h2>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How long does the Mounjaro plateau at 6 months typically last?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">A true Mounjaro plateau lasting longer than 8 weeks is uncommon when patients implement metabolic recalibration \u2014 specifically adding resistance training and adjusting protein intake to 1.0\u20131.2g per pound of body weight. Most plateaus resolve within 3\u20136 weeks of intervention because the stall is driven by reversible factors like NEAT suppression and lean mass loss, not permanent treatment resistance. If the plateau persists beyond 8 weeks despite confirmed adherence to medication and nutritional adjustments, consultation with the prescribing provider to evaluate thyroid function or consider dose titration to 15mg weekly is warranted.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I break through a Mounjaro plateau without increasing my dose?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes \u2014 the majority of patients break through the Mounjaro plateau at 6 months by addressing metabolic adaptation rather than increasing medication dose. Adding resistance training 2\u20133 times weekly increases resting metabolic rate by 30\u201360 calories per day per pound of muscle gained, directly countering the RMR decrease from weight loss. Simultaneously increasing protein to 1.0\u20131.2g per pound of goal weight and distributing it across three meals preserves lean mass during continued deficit. Clinical evidence shows these interventions restart weight loss in 60\u201375% of plateau cases without requiring dose escalation.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What is the difference between a Mounjaro plateau and normal weight fluctuation?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">A true Mounjaro plateau is defined as zero change in body weight and measurements (waist, hips, thighs) for four consecutive weeks, with confirmed medication adherence and stable dietary intake. Normal fluctuation shows 2\u20135 lb swings across a week due to water retention, sodium intake, menstrual cycle, or bowel patterns \u2014 daily weigh-ins plotted on a trend line still show a downward slope over 7\u201314 days. If weekly averages are stable for four weeks and circumference measurements haven&#8217;t changed, that&#8217;s a plateau. If the scale bounces but the 7-day rolling average is still declining, that&#8217;s fluctuation.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Will stopping Mounjaro and restarting later break the plateau?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">No \u2014 stopping tirzepatide and restarting after a washout period does not &#8216;reset&#8217; metabolic adaptation and typically leads to partial weight regain during the off period. The SURMOUNT-1 withdrawal cohort regained an average of 14% of lost weight within 17 weeks of discontinuation. The plateau is caused by decreased total daily energy expenditure and lean mass loss, not receptor desensitisation \u2014 taking a drug holiday doesn&#8217;t reverse those changes. Structured refeeds at maintenance calories while staying on medication are far more effective at breaking stalls without disrupting long-term adherence.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How much protein should I eat to avoid a Mounjaro plateau at 6 months?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Target 1.0\u20131.2g of protein per pound of goal body weight, distributed across at least three meals of 30\u201340g each to meet the leucine threshold for muscle protein synthesis. For a patient with a goal weight of 150 lbs, that&#8217;s 150\u2013180g daily protein split into meals of 40g, 50g, and 50g rather than two larger meals. Front-load the largest portion at breakfast when appetite suppression from Mounjaro is typically lowest. Patients who maintain this intake combined with resistance training show 40\u201360% lower plateau rates at six months compared to those consuming 0.6\u20130.9g\/lb.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Is the Mounjaro plateau at 6 months permanent?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">No \u2014 the Mounjaro plateau is a temporary metabolic adaptation, not permanent treatment failure. It occurs because your total daily energy expenditure has decreased proportionally with weight loss, narrowing the caloric deficit created by appetite suppression. Adding resistance training, increasing protein intake, and implementing periodic refeeds at maintenance calories reverses the lean mass loss and NEAT suppression driving the plateau. Clinical data shows patients who make these adjustments typically resume weight loss within 3\u20136 weeks and go on to lose an additional 10\u201318% of starting body weight between months 6\u201312.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Should I reduce calories more aggressively if I hit a plateau on Mounjaro?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">No \u2014 further caloric restriction below the deficit already created by Mounjaro often compounds metabolic adaptation by triggering additional NEAT suppression and lean mass loss. If you&#8217;ve hit a plateau, the issue isn&#8217;t insufficient restriction; it&#8217;s that your total daily energy expenditure has contracted to match your current intake. Adding a 200\u2013300 calorie deficit works tactically for 2\u20133 weeks but becomes unsustainable and increases rebound risk. The evidence-backed approach is to add muscle-preserving resistance training and implement periodic refeeds, which address the root cause rather than deepening the deficit.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can thyroid problems cause a Mounjaro plateau at 6 months?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Prolonged caloric deficit \u2014 even when mediated by GLP-1 appetite suppression \u2014 can reduce free T3 (triiodothyronine) by 10\u201318% from baseline as an adaptive response to conserved energy expenditure. This isn&#8217;t hypothyroidism requiring medication, but it does contribute to metabolic slowdown. If a plateau persists beyond 8 weeks despite nutrition and training interventions, thyroid function testing (TSH, free T3, free T4) is appropriate. However, most cases resolve with resistance training and structured refeeds before thyroid intervention is necessary \u2014 metabolic adaptation, not thyroid dysfunction, is the primary driver.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How does Mounjaro plateau compare to Ozempic or Wegovy plateau timing?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Plateau timing is similar across GLP-1 medications \u2014 semaglutide (Ozempic, Wegovy) patients typically plateau between months 5\u20138, and tirzepatide (Mounjaro) patients between months 4\u20137. The plateau occurs when metabolic adaptation catches up to medication-driven weight loss, which is determined by rate of weight loss and resulting TDEE contraction, not the specific receptor agonist used. Tirzepatide&#8217;s dual GLP-1\/GIP mechanism produces slightly faster initial weight loss, which can trigger plateau marginally earlier, but the underlying metabolic cause and the interventions required to break it are identical across all GLP-1 therapies.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What body composition changes happen during a Mounjaro plateau?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">During a Mounjaro plateau, the scale may remain stable while body composition continues shifting if resistance training is part of the protocol \u2014 patients can lose fat and gain muscle simultaneously, resulting in no net weight change but measurable reductions in waist and hip circumference. This is why tracking measurements and strength progression matters as much as scale weight. Conversely, plateaus without training often show stable weight but continued muscle loss offset by water retention, which maintains scale weight while worsening metabolic rate. Body composition analysis (DEXA, InBody) every 8\u201312 weeks clarifies whether a plateau represents stalled progress or recomposition.<\/p>\n<\/div>\n<\/details>\n<style>.faq-item summary{outline:none;margin-bottom:0!important;padding-bottom:0!important;}.faq-item summary::-webkit-details-marker{display:none;}.faq-item[open] .faq-arrow{transform:rotate(180deg);}.faq-item>div{margin-top:0!important;padding-top:0!important;}.faq-item p{margin-top:0!important;}<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Hitting a Mounjaro plateau at 6 months is common and reversible \u2014 this is when metabolism adapts to your new weight, not when the medication stops working.<\/p>\n","protected":false},"author":6,"featured_media":98005,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Mounjaro Plateau 6 Months \u2014 Why It Happens and What to Do","_yoast_wpseo_metadesc":"Hitting a Mounjaro plateau at 6 months is common and reversible \u2014 this is when metabolism adapts to your new weight, not when the medication stops working.","_yoast_wpseo_focuskw":"mounjaro plateau 6 months","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[1],"tags":[],"class_list":["post-98006","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/98006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=98006"}],"version-history":[{"count":0,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/98006\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/98005"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=98006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=98006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=98006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}